Insiders Spexis AG

Equities

Market Closed - Swiss Exchange Other stock markets 16:30:28 20/06/2024 BST			5-day change	1st Jan Change
0.031 ^CHF	+0.65%		-25.12%	-24.39%

06-12	Spexis Resumes Trading on the SIX Swiss Exchange	MT
06-05	Spexis Appeals Suspension of Trading on SIX Swiss Exchange	MT

Ascom Hires New CFO	03-21	MT
Muriel Fleming Joins Spexis AG as Executive Committee, Effective December 1, 2023	11-01	CI
Spexis AG Announces Appointment of Gonçalo Bernardes as Acting Head of Chemical Biology	28/09/23	CI
Destiny Pharma picks interim CEO as Clark makes quick exit	25/05/23	AN
Polyphor Finalizes Merger With EnBiotix, to Change Name to Spexis	30/12/21	MT
Polyphor, EnBiotix Shareholders Green-Light Merger, Name Change	29/10/21	MT
Polyphor AG Announces Executive Changes	29/10/21	CI
Polyphor AG Announces Executive Changes	27/09/21	CI
Jean-Pierre Obrecht Announces Not to Stand for Re-Election to Its Board of Directors of Polyphor AG	05/05/20	CI
Polyphor AG Announces Executive Changes	23/01/20	CI
Polyphor Ag Announces Management Changes	20/11/19	CI
Polyphor AG Announces Appointment of Frank Weber as Chief Medical and Development Officer, Effective September 1, 2019	19/07/19	CI
Polyphor AG Appoints Gökhan Batur as Chief Commercial Officer, Effective from June 3, 2019	09/04/19	CI
Debra Barker to Leave from Polyphor as Chief Medical and Development Officer	24/10/18	CI
Polyphor Names Kalina Scott as Chief Financial Officer, Effective from June 1St, 2017	23/05/17	CI
Polyphor Announces Executive Changes	20/03/17	CI
Polyphor Appoints Debra Barker as Chief Medical and Development Officer, Effective May 01, 2017	06/03/17	CI
Polyphor AG Appoints Giacomo Di Nepi as CEO, Effective November 1, 2016	18/10/16	CI
Polyphor Ltd. Announces Management Changes	16/03/15	CI
Polyphor Ltd Announces Board Changes	10/06/13	CI

No results for this search